UBS/CALL/GALENICA/80.002/0.05/20.12.24 | Market Closed - Swiss Exchange 11:20:00 2024-05-10 EDT | ||
| 0.06 CHF | +20.00% |
|
| 1 month | -14.29% | ||
| 3 months | -57.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
GALENICA AG
Latest news about GALENICA AG
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 0.06 | +20.00% | 0 |
Delayed Quote Swiss Exchange
Last update May 10, 2024 at 11:20 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | GALENICA AG |
| Issuer | UBS |
| FGAL0U | |
| ISIN | CH1276040909 |
| Date issued | 2023-06-19 |
| Strike | 80 CHF |
| Maturity | 2024-12-20 (222 Days) |
| Parity | 20 : 1 |
| Emission price | 0.24 CHF |
| Emission volume | N/A |
| Settlement | physical |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.23 CHF |
|---|---|
| Lowest since issue | 0.05 CHF |
| Spread | 0.01 CHF |
| Spread % | 14.29% |
Company Profile
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Sector
-
Consensus: Galenica AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
71.55
CHF
Average target price
76.25
CHF
Spread / Average Target
+6.57%
- Stock Market
- Warrants
- FGAL0U Warrant
